Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
Also Known As
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Legal Names
Legal name
Similar Companies1000
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals is a biopharmaceutical company that develops and commercializes therapies for serious diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
Apellis Pharmaceuticals
Apellis Pharmaceuticals develops therapeutics for chronic inflammatory lung diseases.
Sector
Subsector
Location
total rounds
total raised
Conatus Pharmaceuticals
Conatus Pharmaceuticals is a biotechnology company focused on developing and commercializing innovative medicines to treat chronic diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
Catalyst Pharmaceuticals Partners
Catalyst Pharmaceuticals develops therapies for rare neuromuscular and neurological diseases.
Sector
Subsector
Location
total rounds
total raised
Financials
Funding Rounds8
Number of Funding Rounds
Money Raised
Their latest funding was raised on 29.06.2016. Their latest round Convertible Note
Co-Investors
Investors6
Number of lead investors
Number of investors
Genextra
Genextra is a Milan-based venture capital firm that invests in early-stage life science companies.
Sector
Subsector
Keywords
Location
count Of Investments
Balyasny Asset Management
Balyasny Asset Management delivers consistent, uncorrelated absolute returns.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
OrbiMed
OrbiMed is a healthcare-focused investment firm managing approximately $5 billion in assets.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Chau Khuong
Chau Q. Khuong joined OrbiMed Advisors in 2003 and is a Partner on the Private Equity team. Chau Khuong has experience in start-up operations and business development at Veritas Medicine, Inc. and in basic science research at the Yale School of Medicine and at Massachusetts General Hospital. He was a summer Associate in the New Ventures technology transfer group at Columbia University. At OrbiMed, Chau Khuong was actively involved investments in Arius Research, Inc. (acquired by Roche in 2008), Peninsula Pharmaceuticals, Inc. (acquired by Johnson & Johnson, Inc., in 2005), Cerexa, Inc. (acquired by Forest Laboratories, Inc., in 2007), Adiana, Inc. (acquired by Cytyc Corporation in 2007), Avanir (NASDAQ: AVNR), and Biodel, Inc. (NASDAQ: BIOD). He currently serves as Director or Observer on the Corporate Boards at Cerapedics, Glaukos Corporation, Intercept Pharma, Sonendo, and Pieris AG. Chau Khuong holds a BS in molecular biology with concentration in biotechnology and an MPH with concentration in infectious diseases, both from Yale University.
current job
count Of Investments
People
Founders2
Roberto Pellicciari
current job
organization founded
Roberto Pellicciari
Mark Pruzanski
Mark Pruzanski is the Chairman and Chief Executive Officer of Versanis Bio. He previously worked at National Geographic as an International Council of Advisors. Mark Pruzanski attended The Johns Hopkins University - Paul H. Nitze School of Advanced International Studies (SAIS).
current job
Mark Pruzanski
Employee Profiles161
Maximilian Pawelke
Senior director, us sales planning
Aditya Venugopal
Executive director, head of strategic planning
Activity
Recent News19
The graph reveals the ratio (%) of positive news articles in a chosen time range